Author

Wenyan He

China Pharmaceutical UniversityPrimary ORCID profile (0000-0002-8752-4768 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Wenyan HeiD1 paper · Capital Medical University

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Lingman MaiD· 1 shared Nan LiuiD· 1 shared Qisen Deng· 1 shared Tao Chen· 1 shared Wen XiaoiD· 1 shared Xueting Huan· 1 shared Yijun CheniD· 1 shared Yinchuan LiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Lingman MaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A novel broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance

Wenyan He, Xueting Huan, Yinchuan Li, Qisen Deng, Tao Chen, Wen Xiao, Yijun Chen, Lingman Ma, Nan Liu, Zhuo Shang, Zongqiang Wang

This paper discovers a novel antibiotic, paenimycin, that targets multiple-drug-resistant bacteria through a dual-binding mechanism and shows no detectable resistance.

Nature Communications · Jul 31, 2025Peer-reviewedBiochemistry